We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+7.5%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$75.4B
AUM Growth
+$2.26B
Cap. Flow
-$978M
Cap. Flow %
-1.3%
Top 10 Hldgs %
10.8%
Holding
4,600
New
524
Increased
1,665
Reduced
1,689
Closed
668

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$734M
2
BA icon
Boeing
BA
+$493M
3
PFE icon
Pfizer
PFE
+$478M
4
UNH icon
UnitedHealth
UNH
+$440M
5
HON icon
Honeywell
HON
+$364M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.05B
2
AMD icon
Advanced Micro Devices
AMD
+$447M
3
TSM icon
TSMC
TSM
+$441M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$372M
5
XOM icon
ExxonMobil
XOM
+$321M

Sector Composition

Rank Sector Weight
1 Healthcare 20.34%
2 Technology 16.84%
3 Consumer Discretionary 12.66%
4 Industrials 10.11%
5 Consumer Staples 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYMX
3801
DELISTED
Nymox Pharmaceutical Corp
NYMX
$24K ﹤0.01%
69,381
-13,419
-16% -$5.45K
LABP
3802
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$24K ﹤0.01%
7,920
-4,620
-37% -$17.1K
CREG
3803
DELISTED
Smart Powerr
CREG
$23K ﹤0.01%
+151
New +$27.7K
JF
3804
J and Friends Holdings
JF
$16.8M
$23K ﹤0.01%
+21,017
New +$12K
BACK
3805
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$23K ﹤0.01%
5,249
+4,172
+387% +$30.2K
UNAM
3806
DELISTED
Unico American Corp
UNAM
$23K ﹤0.01%
20,937
+200
+1% +$244
BFRI icon
3807
Biofrontera
BFRI
$15M
$22K ﹤0.01%
1,787
+790
+79% +$12.3K
HSCS icon
3808
Heart Test Laboratories
HSCS
$8.5M
$22K ﹤0.01%
227
-2
-0.9% -$270
VERO
3809
DELISTED
Venus Concept
VERO
$22K ﹤0.01%
618
+153
+33% +$6.8K
GLS
3810
DELISTED
Gelesis Holdings, Inc.
GLS
$22K ﹤0.01%
135,064
+64,242
+91% +$18.4K
BDRX
3811
Biodexa Pharmaceuticals
BDRX
$1.34M
$21K ﹤0.01%
+1
New +$225K
EVOK
3812
DELISTED
Evoke Pharma
EVOK
$21K ﹤0.01%
+932
New +$36.5K
INSG icon
3813
Inseego
INSG
$114M
$21K ﹤0.01%
3,600
+1,200
+50% +$10.7K
MDIA icon
3814
Mediaco Holding
MDIA
$76.6M
$21K ﹤0.01%
+18,300
New +$23.9K
IMDX
3815
Insight Molecular Diagnostics
IMDX
$150M
$21K ﹤0.01%
2,980
+1,570
+111% +$11.7K
GPUS
3816
Hyperscale Data Inc
GPUS
$55.4M
$21K ﹤0.01%
1
TLIS
3817
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$21K ﹤0.01%
2,833
+506
+22% +$4.3K
LYT
3818
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
$21K ﹤0.01%
550
-345
-39% -$16.8K
CWBR
3819
DELISTED
CohBar, Inc. Common Stock
CWBR
$21K ﹤0.01%
11,723
+1,466
+14% +$2.96K
GAME icon
3820
GameSquare
GAME
$34.6M
$20K ﹤0.01%
+3,625
New +$20.7K
INKT icon
3821
MiNK Therapeutics
INKT
$52.3M
$20K ﹤0.01%
+1,030
New +$22.3K
JFU
3822
9F Inc
JFU
$23.9M
$20K ﹤0.01%
12,582
+5,296
+73% +$15.6K
FRZA
3823
DELISTED
Forza X1, Inc. Common Stock
FRZA
$20K ﹤0.01%
16,600
-1,336
-7% -$1.88K
ZEV
3824
DELISTED
Lightning eMotors, Inc.
ZEV
$20K ﹤0.01%
+3,460
New +$40.3K
NMTR
3825
DELISTED
9 Meters Biopharma
NMTR
$20K ﹤0.01%
14,325
-58,843
-80% -$111K

Similar funds

Renaissance Technologies's Q1 2023 Portfolio in Review

As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
  • Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
  • Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
  • Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
  • Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
  • Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.